LINK OUT* will be a semi-regular feature where we profile news from outside the Gawker-verse that relates to making scientific information relatable and useful to you.
Often there will be links to further in-depth readings and resources to help build your knowledge on a topic through various methods and means. (see below for other differences from regular SME posts and the SME Science Reading Roundups)
Slate's Outward blog has an article out today about CDC's support of Truvada as an HIV prevention method. While I disagree with their headline using the term 'miracle drug', the rest of what Stern writes is pretty much on spot.
The Centers for Disease Control and Prevention (CDC) released new guidelines on May 14th on the use of TDF/FTC (brand name Truvada) as a pre-exposure prophylaxis to prevent HIV infection. TDF/FTC (Tenofovir/emtricitabine) is a combination anti-retroviral drug that was originally developed to treat HIV infection. Tenofovir and emtricitabine inhibits HIV from replicating inside an infected cell.
PrEP adds to a growing 'tool box' of HIV prevention tools.
Tuesday May 20th at 10am EST
ProTip: Not affiliated with the HIV prevention field? No worries, AVAC encourages community advocates to join their webinars.
*1 I'm open to suggestions for naming of these sort of posts, but Link Out was what came to mind first. If you have a suggestion then let me know in the comments.
*2 Link Out posts are not posts of original writing nor are they collections from within the Kinja-verse like Science Reading Roundups. They are bits and pieces, links and writing from outside our little corner of the interwebs.
**The Global Campaign for Microbicides closed in September 2012, however the materials found in the link above still have relevance in the field. Disclosure: I worked for the Global Campaign for Microbicides from 2007 – 2010.